Shuai Wu
Impact in
-
- IL-33, ST2, and ILC Pathways
Papers in
-
- Cancer-related gene regulation 3
- Glycosylation and Glycoproteins Research 2
- Ubiquitin and proteasome pathways 2
- Inflammasome and immune disorders 2
- Oncology 6
- Pancreatic and Hepatic Oncology Research 5
- Co-authors
- Zheng Wang (4 shared papers)Yangyang Yue (4 shared papers)Weikun Qian (6 shared papers)Simei Zhang (5 shared papers)Wunai Zhang (5 shared papers)Tao Qin (1 shared paper)Li Li (1 shared paper)Ying Xiao (1 shared paper)
- Journals
- Advanced Science (1 paper)Oxidative Medicine and Cellular Longevity (1 paper)International Immunopharmacology (1 paper)Journal of Hepato-Biliary-Pancreatic Sciences (1 paper)Advanced Functional Materials (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Shuai Wu
19 papers receiving 499 citations
Shuai Wu's Hit Papers
Peers
Comparison fields: 5 of 75
- Biological Psychiatry 15
- Immunology 88
- Molecular Biology 278
- Nephrology 21
- Oncology 65
Countries citing papers authored by Shuai Wu
This map shows the geographic impact of Shuai Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuai Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuai Wu more than expected).
Fields of papers citing papers by Shuai Wu
This network shows the impact of papers produced by Shuai Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuai Wu. The network helps show where Shuai Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Shuai Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | NLRP3 Inflammasome and Inflammatory Diseases Hit paper breakdown → | 2020 | 267 |
| 2 | 1993 | 85 | |
| 3 | 2022 | 43 | |
| 4 | 2022 | 24 | |
| 5 | 2022 | 24 | |
| 6 | 2022 | 14 | |
| 7 | 2024 | 12 | |
| 8 | 2025 | 10 | |
| 9 | 2025 | 6 | |
| 10 | 2023 | 4 | |
| 11 | 2022 | 3 | |
| 12 | 2024 | 2 | |
| 13 | 2023 | 2 | |
| 14 | 2025 | 2 | |
| 15 | 2022 | 1 | |
| 16 | 2025 | 1 | |
| 17 | 2016 | 1 | |
| 18 | 2023 | 1 | |
| 19 | 2024 | 1 | |
| 20 | 2025 | 0 |
About Shuai Wu
Shuai Wu is a scholar working on Molecular Biology, Oncology, Cell Biology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 25 papers that have together received 503 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (5 papers), Cancer-related gene regulation (3 papers), Caveolin-1 and cellular processes (3 papers), Ferroptosis and cancer prognosis (2 papers), Glycosylation and Glycoproteins Research (2 papers), Ubiquitin and proteasome pathways (2 papers), Hippo pathway signaling and YAP/TAZ (2 papers) and Inflammasome and immune disorders (2 papers). The work is most often cited by research in Biological Psychiatry (15 citations), Immunology (88 citations), Molecular Biology (278 citations), Nephrology (21 citations) and Oncology (65 citations). Shuai Wu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Zheng Wang, Yangyang Yue, Weikun Qian, Simei Zhang, Wunai Zhang, Tao Qin, Li Li, Ying Xiao, Kay Huebner and Teresa Druck. Their work appears in journals such as Advanced Science, Oxidative Medicine and Cellular Longevity, International Immunopharmacology, Journal of Hepato-Biliary-Pancreatic Sciences and Advanced Functional Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.